Because oncology research challenges demand specialized knowledge

Success is in the details

With experience comes a degree of sophistication that shows in small things that, taken together, make a big difference. We also maintain close ties with the oncology community—opinion leaders, professional organizations, and other stakeholders—who bring us additional insights that benefit your studies.

You know as well as we do that the unique patient populations, study design challenges, and special endpoints associated with oncology trials all demand specialized knowledge. Our expert oncology staff is uniquely qualified to address the challenges of oncology research—and help you bring critical products to market faster.

i3 is uniquely positioned for the complexity of oncology trials. Our experience spans many indications, interventions, and phases of oncology drug development.

Category experience and expertise

i3 oncology experience spans the spectrum of oncology indications and phases of research and gives us a superb view of the entire clinical trial process—helping us provide insight into your overall program development. Our highly accomplished project teams draw from a rich history of corporate and individual experiences to deliver optimal value to your study:

  • Our team includes board-certified oncologists and hematologists whose medical oversight is closely integrated into all project teams, allowing therapeutic understanding to enhance every aspect of your trial
  • Our therapeutically focused CRAs and project managers average five or more years of experience, and their therapeutic alignment gives them unique oncology knowledge
  • We maintain access to more than 300 oncology professionals worldwide

Why i3?

Our experience works to your advantage: we’ve provided the full spectrum of CRO services from stand-alone clinical monitoring to final study reporting for Phase I–IV oncology trials at more than 3,000 sites globally, targeting the enrollment of more than 18,000 oncology patients since January 2002.